Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis

Molecular Neurobiology

Volumn 54, Issue 3, 2017, Pages 2031-2044

  Schiavone, Stefania ^a   Mhillaj, Emanuela ^b   Neri, Margherita ^a   Morgese, Maria Grazia ^a   Tucci, Paolo ^a   Bove, Maria ^b   Valentino, Mario ^c   Di Giovanni, Giuseppe ^c   Pomara, Cristoforo ^a   Turillazzi, Emanuela ^a   Trabace, Luigia ^a   Cuomo, Vincenzo ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MALTA   (Malta)

Author keywords

Blood brain barrier; NADPH oxidase; Oxidative stress; Psychosis; Social isolation

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; OCCLUDIN; OCCLUDIN 1; PLASMALEMMAL VESICLE ASSOCIATED PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG; CYBB PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; INTERSTITIAL FLUID; LENG8 GENE; MALE; MENTAL STRESS; NONHUMAN; NOX2 GENE; ORL GENE; OXIDATIVE STRESS; PATHOGENESIS; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PSYCHOSIS; RAT; SOCIAL ISOLATION; TRANK 1 GENE; VNR1 GENE; VOF 16 GENE; VOF 21 GENE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; ENZYMOLOGY; PATHOLOGY; PSYCHOLOGY; WISTAR RAT;

ANIMALS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; FEMALE; MALE; NADPH OXIDASE 2; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; RATS; RATS, WISTAR; SOCIAL ISOLATION;

EID: 84959165875     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9791-8     Document Type: Article

References (55)

1. Schiavone S, Jaquet V, Sorce S, Dubois-Dauphin M, Hultqvist M, Backdahl L, Holmdahl R, Colaianna M, Cuomo V, Trabace L, Krause KH (2012) NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Translational Psychiatry 2:e111. doi:10.1038/tp.2012.36
2. Ozyurt H, Ozyurt B, Sarsilmaz M, Kus I, Songur A, Akyol O (2014) Potential role of some oxidant/antioxidant status parameters in prefrontal cortex of rat brain in an experimental psychosis model and the protective effects of melatonin. Eur Rev Med Pharmacol Sci 18(15):2137–2144
3. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245–313. doi:10.1152/physrev.00044.2005
4. Infanger DW, Sharma RV, Davisson RL (2006) NADPH oxidases of the brain: distribution, regulation, and function. Antioxidants & redox signaling 8(9-10):1583–1596. doi:10.1089/ars.2006.8.1583
5. Sorce S, Krause KH (2009) NOX enzymes in the central nervous system: from signaling to disease. Antioxidants Redox Signal 11(10):2481–2504. doi:10.1089/ARS.2009.2578
6. Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V, Dubois-Dauphin M, Trabace L, Krause KH (2010) The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci Off J Soc Neurosci 30(34):11317–11325. doi:10.1523/JNEUROSCI.1491-10.2010
7. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318(5856):1645–1647. doi:10.1126/science.1148045
8. Powell SB, Sejnowski TJ, Behrens MM (2012) Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 62(3):1322–1331. doi:10.1016/j.neuropharm.2011.01.049
9. Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology 156(2-3):305–326
10. Leng A, Feldon J, Ferger B (2004) Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav 77(2):371–379
11. King MV, Seeman P, Marsden CA, Fone KC (2009) Increased dopamine D2High receptors in rats reared in social isolation. Synapse 63(6):476–483. doi:10.1002/syn.20624
12. Geyer MA, Ellenbroek B (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27(7):1071–1079. doi:10.1016/j.pnpbp.2003.09.003
13. Lapiz MD, Fulford A, Muchimapura S, Mason R, Parker T, Marsden CA (2003) Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol 33(1):13–29
14. Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP (2007) Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm 114(7):893–898. doi:10.1007/s00702-007-0627-6
15. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, Krause KH (2009) Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66(4):384–392. doi:10.1016/j.biopsych.2009.04.033
16. Rochfort KD, Cummins PM (2015) The blood-brain barrier endothelium: a target for pro-inflammatory cytokines. Biochem Soc Trans 43(4):702–706. doi:10.1042/BST20140319
17. van Dijk G, van Heijningen S, Reijne AC, Nyakas C, van der Zee EA, Eisel UL (2015) Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci 9:173. doi:10.3389/fnins.2015.00173
18. Najjar S, Pearlman DM (2015) Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 161(1):102–112. doi:10.1016/j.schres.2014.04.041
19. Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, Meyer JH, Wilson AA, Houle S, Mizrahi R (2015) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41(1):85–93. doi:10.1093/schbul/sbu157
20. Nurulain SM, Adeghate E, Sheikh A, Yasin J, Kamal MA, Sharma C, Adem A, Ojha S (2014) Sub-chronic exposure of non-observable adverse effect dose of terbufos sulfone: neuroinflammation in diabetic and non-diabetic rats. CNS Neurol Disorders Drug Targets 13(8):1397–1405
21. Uchizono Y, Takeya R, Iwase M, Sasaki N, Oku M, Imoto H, Iida M, Sumimoto H (2006) Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci 80(2):133–139. doi:10.1016/j.lfs.2006.08.031
22. Neri M, Cantatore S, Pomara C, Riezzo I, Bello S, Turillazzi E, Fineschi V (2011) Immunohistochemical expression of proinflammatory cytokines IL-1beta, IL-6, TNF-alpha and involvement of COX-2, quantitatively confirmed by Western blot analysis, in Wernicke's encephalopathy. Pathol Res Pract 207(10):652–658. doi:10.1016/j.prp.2011.07.012
23. Radu M, Chernoff J (2013) An in vivo assay to test blood vessel permeability. J Visualized Exp JoVE 73:e50062. doi:10.3791/50062
24. Lin Y, Pan Y, Wang M, Huang X, Yin Y, Wang Y, Jia F, Xiong W, Zhang N, Jiang JY (2012) Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat. Lab Investig J Tech Meth Pathol 92(11):1623–1634. doi:10.1038/labinvest.2012.118
25. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A, Fisher M, Kaps M, Bachmann G (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke J Cerebral Circulation 35(2):566–571. doi:10.1161/01.STR.0000113692.38574.57
26. Halle M, Gabrielsen A, Paulsson-Berne G, Gahm C, Agardh HE, Farnebo F, Tornvall P (2010) Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol 55(12):1227–1236. doi:10.1016/j.jacc.2009.10.047
27. Egleton RD, Davis TP (2005) Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx J Am Soc Exp NeuroTherapeutics 2(1):44–53. doi:10.1602/neurorx.2.1.44
28. Sandoval A, Fraisl P, Arias-Barrau E, Dirusso CC, Singer D, Sealls W, Black PN (2008) Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Arch Biochem Biophys 477(2):363–371. doi:10.1016/j.abb.2008.06.010
29. Nunez CC, Roussotte F, Sowell ER (2011) Focus on: structural and functional brain abnormalities in fetal alcohol spectrum disorders. Alcohol Res Health J Nation Institute Alcohol Abuse Alcohol 34(1):121–131
30. Zehendner CM, White R, Hedrich J, Luhmann HJ (2014) A neurovascular blood-brain barrier in vitro model. Methods Mol Biol 1135:403–413. doi:10.1007/978-1-4939-0320-7_33
31. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173–1175. doi:10.1038/nm1651
32. Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, Walter KA (2008) Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC Neurosci 9:29. doi:10.1186/1471-2202-9-29
33. Hanson DR, Gottesman II (2005) Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 6:7. doi:10.1186/1471-2350-6-7
34. Bayard-Burfield L, Alling C, Blennow K, Jonsson S, Traskman-Bendz L (1996) Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol J Eur College Neuropsychopharmacol 6(3):195–199
35. Zetterberg H, Jakobsson J, Redsater M, Andreasson U, Palsson E, Ekman CJ, Sellgren C, Johansson AG, Blennow K, Landen M (2014) Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Res 217(3):143–146. doi:10.1016/j.psychres.2014.03.045
36. Reiber H (1994) Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122(2):189–203
37. Hirohata S, Sakuma Y, Yanagida T, Yoshio T (2014) Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus. Arthritis Res Therapy 16(5):450. doi:10.1186/s13075-014-0450-z
38. Stolp HB, Dziegielewska KM (2009) Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 35(2):132–146. doi:10.1111/j.1365-2990.2008.01005.x
39. Abdel-Rahman A, Shetty AK, Abou-Donia MB (2002) Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience 113(3):721–741
40. Falcone T, Carlton E, Lee C, Janigro M, Fazio V, Forcen FE, Franco K, Janigro D (2013) Does systemic inflammation play a role in pediatric psychosis? Clin Schizophrenia Related Psychoses:1-43. doi:10.3371/CSRP.FACA.030813
41. Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT (2006) Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry 77(11):1284–1287. doi:10.1136/jnnp.2006.093427
42. Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S, Theoharides TC (2001) Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888(1):117–127
43. Theoharides TC, Konstantinidou AD (2007) Corticotropin-releasing hormone and the blood-brain-barrier. Frontiers Biosci J Virtual Library 12:1615–1628
44. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y (2007) Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101(2):566–576. doi:10.1111/j.1471-4159.2006.04393.x
45. Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cerebral Blood Metab Off J Int Soc Cerebral Blood Flow and Metabolism 21(12):1393–1400. doi:10.1097/00004647-200112000-00003
46. Witt KA, Mark KS, Huber J, Davis TP (2005) Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem 92(1):203–214. doi:10.1111/j.1471-4159.2004.02871.x
47. Lochhead JJ, McCaffrey G, Sanchez-Covarrubias L, Finch JD, Demarco KM, Quigley CE, Davis TP, Ronaldson PT (2012) Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. Am J Physiol Heart Circulat Physiol 302(3):H582–H593. doi:10.1152/ajpheart.00889.2011
48. da Fonseca AC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, Lima FR (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8:362. doi:10.3389/fncel.2014.00362
49. Behrens MM, Ali SS, Dugan LL (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci Off J Soc Neurosci 28(51):13957–13966. doi:10.1523/JNEUROSCI.4457-08.2008
50. Dugan LL, Ali SS, Shekhtman G, Roberts AJ, Lucero J, Quick KL, Behrens MM (2009) IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS One 4(5):e5518. doi:10.1371/journal.pone.0005518
51. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, Brandes RP (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke J Cerebral Circulation 38(11):3000–3006. doi:10.1161/STROKEAHA.107.489765
52. Rochfort KD, Collins LE, Murphy RP, Cummins PM (2014) Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One 9(7):e101815. doi:10.1371/journal.pone.0101815
53. Reeson P, Tennant KA, Gerrow K, Wang J, Weiser Novak S, Thompson K, Lockhart KL, Holmes A, Nahirney PC, Brown CE (2015) Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner. J Neurosci Off J Soc Neurosci 35(13):5128–5143. doi:10.1523/JNEUROSCI.2810-14.2015
54. Roma P, Pompili M, Lester D, Girardi P, Ferracuti S (2013) Incremental conditions of isolation as a predictor of suicide in prisoners. Forensic Sci Int 233(1-3):e1–e2. doi:10.1016/j.forsciint.2013.08.016
55. Duthe G, Hazard A, Kensey A, Shon JL (2013) Suicide among male prisoners in France: a prospective population-based study. Forensic Sci Int 233(1-3):273–277. doi:10.1016/j.forsciint.2013.09.014